Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Intidhar Labidi

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Advances in Experimental Medicine and Biology|June 11, 2017
Clinical Development of Anti-mitotic Drugs in CancerAnna-Maria Olziersky, S Intidhar Labidi-Galy
Seminars in Cancer Biology|September 15, 2020
Challenges for immunotherapy for the treatment of platinum resistant ovarian cancerOlivia Le Saux, Isabelle Ray-Coquard, S Intidhar Labidi-Galy
Gynecologic Oncology Reports|November 7, 2024
Ovarian stimulation with letrozole in nulliparous young women with relapsing early-stage serous borderline ovarian tumorsValeria Lombardi Fäh, Federico Del Vento, S Intidhar Labidi-Galy, et al.
Critical Reviews in Oncology/Hematology|March 12, 2016
Ovarian cancer: Status of homologous recombination pathway as a predictor of drug responseNicolas De Picciotto, Wulfran Cacheux, Arnaud Roth, et al.
Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris|November 8, 2006
[Papillary-follicular carcinoma arising in a lingual thyroid]A M'hiri Chaabouni, S Intidhar Labidi, T Kraiem, et al.
Gynecologic Oncology Reports|July 3, 2020
Sustained response to pembrolizumab without prior chemotherapy in high-grade serous ovarian carcinoma with <i>CSMD3</i> mutationJulie Terzic, Amanda Seipel, Jean Dubuisson, et al.
Gynecologic Oncology Reports|April 22, 2024
Window of opportunity with PD1 blockade before chemoradiotherapy for an advanced stage clear cell carcinoma of the cervixMarie-Gabrielle Courtès, Melpomeni Kountouri, Wenwen Wang, et al.
Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris|November 8, 2006
[Thyroid carcinoma and Hashimoto thyroiditis]S Intidhar Labidi, A M'Hiri Chaabouni, T Kraiem, et al.
Annals of Translational Medicine|January 25, 2021
Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets-a narrative reviewEleftherios P Samartzis, S Intidhar Labidi-Galy, Michele Moschetta, et al.
Gynecologic Oncology|January 28, 2014
Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancerKristina A Williams, S Intidhar Labidi-Galy, Kathryn L Terry, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Advances in Experimental Medicine and Biology|June 11, 2017
Clinical Development of Anti-mitotic Drugs in CancerAnna-Maria Olziersky, S Intidhar Labidi-Galy
Seminars in Cancer Biology|September 15, 2020
Challenges for immunotherapy for the treatment of platinum resistant ovarian cancerOlivia Le Saux, Isabelle Ray-Coquard, S Intidhar Labidi-Galy
Gynecologic Oncology Reports|November 7, 2024
Ovarian stimulation with letrozole in nulliparous young women with relapsing early-stage serous borderline ovarian tumorsValeria Lombardi Fäh, Federico Del Vento, S Intidhar Labidi-Galy, et al.
Critical Reviews in Oncology/Hematology|March 12, 2016
Ovarian cancer: Status of homologous recombination pathway as a predictor of drug responseNicolas De Picciotto, Wulfran Cacheux, Arnaud Roth, et al.
Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris|November 8, 2006
[Papillary-follicular carcinoma arising in a lingual thyroid]A M'hiri Chaabouni, S Intidhar Labidi, T Kraiem, et al.
Gynecologic Oncology Reports|July 3, 2020
Sustained response to pembrolizumab without prior chemotherapy in high-grade serous ovarian carcinoma with <i>CSMD3</i> mutationJulie Terzic, Amanda Seipel, Jean Dubuisson, et al.
Gynecologic Oncology Reports|April 22, 2024
Window of opportunity with PD1 blockade before chemoradiotherapy for an advanced stage clear cell carcinoma of the cervixMarie-Gabrielle Courtès, Melpomeni Kountouri, Wenwen Wang, et al.
Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris|November 8, 2006
[Thyroid carcinoma and Hashimoto thyroiditis]S Intidhar Labidi, A M'Hiri Chaabouni, T Kraiem, et al.
Annals of Translational Medicine|January 25, 2021
Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets-a narrative reviewEleftherios P Samartzis, S Intidhar Labidi-Galy, Michele Moschetta, et al.
Gynecologic Oncology|January 28, 2014
Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancerKristina A Williams, S Intidhar Labidi-Galy, Kathryn L Terry, et al.
Pageof 3